General
Final KEYNOTE-006 OS analysis confirms efficacy of pembrolizumab in advanced melanoma | News for Doctor, Nurse, Pharmacist | Multidisciplinary | MIMS Malaysia
 

Final KEYNOTE-006 OS analysis confirms efficacy of pembrolizumab in advanced melanoma | News for Doctor, Nurse, Pharmacist | Multidisciplinary | MIMS Malaysia

Shared by:

 
Final KEYNOTE-006 OS analysis confirms efficacy of pembrolizumab in advanced melanoma | MIMS Malaysia
 
specialty.mims.com
 
30 Aug 2017 - General
 
Madhubabu kaaja Thank you for sharing more information about pembrolizumab. It is very useful to know that there pembrolizumab is also approved for the treatment of other types of cancer involving the lungs. It is a new , promising chemotherapeutic agent that has been well-documented for treating former US president Jimmy Carter of liver cancer metastases in 2015. Upon checking, it is available in the Philippines....
 (Total 75 words)
Progress in the field of oncology keeps building on as a monoclonal antibody drug named pembrolizumab has been shown to be effective in the treatment of advanced melanoma. Though it does not supplant first-line treatments, it is a promising useful adjunct for treating melanoma due to better tolerability profile. This brings a thought in mind since we are seeing leaps in the field of oncology. I think that the field of infectious diseases' progress in discovering new antibiotics is lagging be...
 (Total 92 words)